HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Qiong J Wang Selected Research

Lysine (L-Lysine)

3/2011Development of a genetically-modified novel T-cell receptor for adoptive cell transfer against renal cell carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Qiong J Wang Research Topics

Disease

13Neoplasms (Cancer)
01/2019 - 05/2004
5Melanoma (Melanoma, Malignant)
03/2016 - 05/2004
2Glioblastoma (Glioblastoma Multiforme)
01/2019 - 10/2018
2Pancreatic Neoplasms (Pancreatic Cancer)
01/2019 - 03/2016
2Renal Cell Carcinoma (Grawitz Tumor)
03/2011 - 02/2009
2Bacterial Vaginosis
11/2005 - 09/2005
1Glioma (Gliomas)
10/2018
1Colorectal Neoplasms (Colorectal Cancer)
03/2016
1Lung Neoplasms (Lung Cancer)
03/2016
1Cholangiocarcinoma
03/2016
1Colitis
02/2009
1Kidney Neoplasms (Kidney Cancer)
02/2009
1Vaginal Discharge
09/2005
1Vaginitis
01/2005
1Myelodysplastic Syndromes (Myelodysplastic Syndrome)
10/2003
1Cytopenia
10/2003
1Infections
05/2002

Drug/Important Bio-Agent (IBA)

4AntigensIBA
03/2016 - 05/2004
3Chimeric Antigen ReceptorsIBA
01/2019 - 05/2017
3Neoplasm Antigens (Tumor Antigens)IBA
10/2018 - 05/2004
2Interleukin-8 (Interleukin 8)IBA
01/2019 - 02/2009
2Proteins (Proteins, Gene)FDA Link
10/2018 - 05/2004
2T-Cell Antigen Receptors (T-Cell Receptor)IBA
03/2016 - 03/2011
2Interleukin-2 (IL2)IBA
11/2010 - 02/2009
2RNA (Ribonucleic Acid)IBA
11/2005 - 01/2005
1Interleukin-8A Receptors (Receptors, Interleukin 8A)IBA
01/2019
1Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA
10/2018
1LigandsIBA
10/2018
1ChemokinesIBA
10/2018
1Codon (Codons)IBA
03/2016
1HLA-A Antigens (HLA-A)IBA
03/2016
1Complementarity Determining Regions (Complementarity Determining Region)IBA
05/2011
1TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA
05/2011
1Matrix Metalloproteinase 14 (MT1-MMP)IBA
05/2011
1Phenylalanine (L-Phenylalanine)FDA Link
03/2011
1Alanine (L-Alanine)FDA Link
03/2011
1Lysine (L-Lysine)FDA Link
03/2011
1Serine (L-Serine)FDA Link
03/2011
1Tyrosine (L-Tyrosine)FDA Link
03/2011
1L-SelectinIBA
01/2011
1Biomarkers (Surrogate Marker)IBA
11/2010
1InterferonsIBA
11/2010
1Programmed Cell Death 1 ReceptorIBA
11/2010
1Trastuzumab (Herceptin)FDA Link
11/2009
1Interleukin-17 (Interleukin 17)IBA
02/2009
1InterleukinsIBA
02/2009
1CTLA-4 AntigenIBA
02/2009
1Interferon-gamma (Interferon, gamma)IBA
02/2009
1IpilimumabIBA
02/2009
1Coloring Agents (Dyes)IBA
09/2005
1Tumor Viral Antigens (Large T Antigen)IBA
05/2004
1Monophenol Monooxygenase (Tyrosinase)IBA
05/2004
1Peptides (Polypeptides)IBA
05/2004
1HLA-B Antigens (HLA-B)IBA
05/2004
1HLA-A2 Antigen (HLA A2 Antigen)IBA
05/2004
1Melanoma-Specific AntigensIBA
05/2004
1HLA-DP Antigens (HLA-DP)IBA
05/2004
1incomplete Freund's adjuvantIBA
05/2004
1Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA
10/2003
1Cyclosporine (Ciclosporin)FDA LinkGeneric
10/2003
1EpitopesIBA
05/2002

Therapy/Procedure

3Immunotherapy
10/2018 - 05/2004
1Radiotherapy
05/2011
1Therapeutics
11/2010
1Cell- and Tissue-Based Therapy (Cell Therapy)
11/2010